Category: Earnings

Digi Power X Inc. reported positive financial results for Q2 2025, achieving a positive Adjusted EBITDA and removing the “going

NextNRG, Inc. (NASDAQ: NXXT) will host a conference call on August 15, 2025, at 9:00 a.m. Eastern Time to discuss

Q2 results from 461 S&P 500 members show total earnings up +11.4% from last year with 80.5% beating EPS estimates.

Beam Global announced its second quarter results for the period ended June 30, 2025. Highlights include a 12% revenue increase

Nuclear energy stocks, like the VanEck Uranium and Nuclear ETF (NYSEARCA: NLR), have seen significant returns of 65% in the

Super League reported Q2 financial results, highlighting gross margin expansion, cost reductions, and revenue diversification initiatives. Despite macro headwinds, gross

KULR Technology Group, Inc. reported a 63% increase in revenue to $3.97 million in the second quarter of 2025, with

BioStem Technologies, Inc. reported preliminary financial results for the second quarter of 2025, including net revenue of $49.3 million and

Flowers Foods, Inc. (FLO) is set to report earnings for the quarter ending June 30, 2025. Analysts forecast earnings per

Jim Cramer discussed the Investing Club’s portfolio during the August Monthly Meeting. Apple’s stock rallied after announcing a $100 billion

After hours on 08/14/2025, companies like Applied Materials, Inc. (AMAT) and Nu Holdings Ltd. (NU) are expected to report earnings.

Shares of Tapestry, parent company of Coach and Kate Spade, dropped due to expected profit losses from tariffs, totaling $160

John Deere projects tariff costs of $600 million for fiscal 2025, causing a 7% stock drop. Operating profits decreased due

The stock market has been surging due to the earnings reports, Trump’s tariff moves, and the Fed’s upcoming monetary policy

Lithium demand is set to rise due to data center needs and Chinese production cuts. Prices surged by 24.2% in

Kartoon Studios reported a 23% increase in Q2 revenue year-over-year, with streaming viewership soaring and cost reductions leading to profitability

Reading International, Inc. announced improved financial results for the second quarter of 2025, with total revenues of $60.4 million, a

Amaze Holdings, Inc. reported Q2 2025 financial results, including $0.87 million in net revenue. The company surpassed 200 million lifetime

Adial Pharmaceuticals provided a business update and reported financial results for Q2 2025. The FDA meeting for AD04, a drug

Candel Therapeutics presented positive phase 3 trial results for CAN-2409 in localized prostate cancer, receiving FDA RMAT Designation and Orphan

Outlook Therapeutics announced the first commercial sales of LYTENAVA™ in Europe for wet AMD treatment. Financial results show a net

MiNK Therapeutics, Inc. extended cash runway to advance clinical program in GVHD, with Ph2 results expected in 2L Gastric Cancer.

BTCS Inc. reported record quarterly revenue of $2.77 million for Q2 2025, a 394% increase year-over-year. The company’s post-quarter ETH

Dillard’s, Inc. reported a 1% increase in total retail sales and comparable store sales in the second quarter of 2025.

Shattuck Labs submitted an Investigational New Drug (IND) application for SL-325 to FDA, expecting clearance in Q3 2025. They plan